antibiotics news from FierceBioResearcher

It turns out that hundreds of bacteria can actually 'eat' antibiotics, according to researchers at Harvard Medical School. The scientific team isolated bacteria in soil and fed them 18 different Read more...

A protein may hold the key to a new vaccine that could effectively target pneumonia, according to Children's Hospital of Pittsburgh of UPMC. Jay K. Kolls, MD, chief of the Division of Pediatric Read more...

Several teams of scientists have been working away at creating new life forms from artificial DNA. In Maryland, for example, one group has stitched together a chromosome and expects to transplant it Read more...

A team of scientists in the UK have designed a genetic tool that can disable genes equipped with antibiotic resistance, an approach that could scuttle superbugs like Read more...

A novel vaccine developed at The Scripps Research Institute at La Jolla may offer a new way to block infections without sparking bacterial resistance--a process that gradually dilutes the Read more...

Stem Cell Research Renowned scientist Ian Wilmut predicts that the first stem cell therapies will become available in about a decade and quickly become as common as antibiotics. Read more...

The NIH has recognized 12 leading scientists with its Pioneer Award. They include Emery N. Brown, M.D., Ph.D., who's studying anesthetics; Stanford's Thomas R. Clandinin, Ph.D., who is studying how Read more...

Researchers at the University of Alabama at Birmingham have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance. In findings published online in two complementary papers in Nature, the research team describes the differences in an enzyme called RNA polymerase in bacterial cells as opposed to human cells. These differences provide potential new targets for drug design.

"Knowing how RNA …

Read more...

Researchers at the University of Warwick are examining a way of using bacteria to manufacture a new suite of potential anti-cancer drugs that are difficult to create synthetically on a lab bench. The bacterium Streptomyces coelicolor naturally produce antibiotics called prodiginines. This group of antibiotics has stimulated much recent interest as they can be used to target and kill cancer cells. A synthetic prodiginine analogue called GX15-070 is currently in phase I and II cancer …

Read more...

More Research

The NIH has begun a new project to sequence all the genetic changes that occur in brain, ovarian and lung cancer. Their work is intended to highlight new genes that will be the target of a new generation of cancer drugs. Report

By switching sugar molecules using a class of enzymes …

Read more...